Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis

M. C. Park, S. W. Lee, S. T. Choi, YongBeom Park, S. K. Lee

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Objective: To determine whether serum leptin levels are elevated in men with ankylosing spondylitis (AS) and whether the levels correlate with serum cytokine profiles and disease activity of AS. Methods: Forty-two male patients with newly diagnosed AS were enrolled. Their Bath AS Disease Activity Index (BASDAI), body mass index (BMI), and acute phase reactants, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels, were assessed. Serum leptin levels were determined using radioimmunoassay (RIA) and serum cytokine profiles, including tumour necrosis factor (TNF)-α, interleukin (IL)-6, and interferon (IFN)-γ, were determined using enzyme-linked immunosorbent assay (ELISA). These results were compared with those from 42 age-matched healthy men. After a follow-up period of 31.0±20.1 months, clinical and biochemical variables were reassessed in the men with AS. Results: At baseline, patients with AS had significantly elevated serum levels of leptin, leptin adjusted for BMI (leptin/BMI), TNFα, and IL-6, but not IFN-γ, as compared to the controls. Serum leptin/BMI levels correlated well with IL-6 levels, and both leptin/BMI and IL-6 levels correlated well with BASDAI and CRP levels in patients with AS. The changes in leptin/BMI and IL-6 levels between the baseline and follow-up measurements correlated well with one another (p<0.05) and both correlated well with the changes in BASDAI (p<0.05). Conclusion: Serum leptin/BMI levels were increased and significantly associated with IL-6 levels and disease activity in men with AS, suggesting a possible role for leptin in the inflammatory reactions of AS.

Original languageEnglish
Pages (from-to)101-106
Number of pages6
JournalScandinavian Journal of Rheumatology
Volume36
Issue number2
DOIs
Publication statusPublished - 2007 May 8

Fingerprint

Ankylosing Spondylitis
Leptin
Interleukin-6
Serum
Baths
C-Reactive Protein
Interferons
Body Mass Index
Tumor Necrosis Factor-alpha
Cytokines
Acute-Phase Proteins
Blood Sedimentation
Radioimmunoassay
Enzyme-Linked Immunosorbent Assay

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

@article{11222dd37aaa48d692ce64610af00cfc,
title = "Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis",
abstract = "Objective: To determine whether serum leptin levels are elevated in men with ankylosing spondylitis (AS) and whether the levels correlate with serum cytokine profiles and disease activity of AS. Methods: Forty-two male patients with newly diagnosed AS were enrolled. Their Bath AS Disease Activity Index (BASDAI), body mass index (BMI), and acute phase reactants, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels, were assessed. Serum leptin levels were determined using radioimmunoassay (RIA) and serum cytokine profiles, including tumour necrosis factor (TNF)-α, interleukin (IL)-6, and interferon (IFN)-γ, were determined using enzyme-linked immunosorbent assay (ELISA). These results were compared with those from 42 age-matched healthy men. After a follow-up period of 31.0±20.1 months, clinical and biochemical variables were reassessed in the men with AS. Results: At baseline, patients with AS had significantly elevated serum levels of leptin, leptin adjusted for BMI (leptin/BMI), TNFα, and IL-6, but not IFN-γ, as compared to the controls. Serum leptin/BMI levels correlated well with IL-6 levels, and both leptin/BMI and IL-6 levels correlated well with BASDAI and CRP levels in patients with AS. The changes in leptin/BMI and IL-6 levels between the baseline and follow-up measurements correlated well with one another (p<0.05) and both correlated well with the changes in BASDAI (p<0.05). Conclusion: Serum leptin/BMI levels were increased and significantly associated with IL-6 levels and disease activity in men with AS, suggesting a possible role for leptin in the inflammatory reactions of AS.",
author = "Park, {M. C.} and Lee, {S. W.} and Choi, {S. T.} and YongBeom Park and Lee, {S. K.}",
year = "2007",
month = "5",
day = "8",
doi = "10.1080/03009740600991760",
language = "English",
volume = "36",
pages = "101--106",
journal = "Scandinavian Journal of Rheumatology",
issn = "0300-9742",
publisher = "Informa Healthcare",
number = "2",

}

Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis. / Park, M. C.; Lee, S. W.; Choi, S. T.; Park, YongBeom; Lee, S. K.

In: Scandinavian Journal of Rheumatology, Vol. 36, No. 2, 08.05.2007, p. 101-106.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis

AU - Park, M. C.

AU - Lee, S. W.

AU - Choi, S. T.

AU - Park, YongBeom

AU - Lee, S. K.

PY - 2007/5/8

Y1 - 2007/5/8

N2 - Objective: To determine whether serum leptin levels are elevated in men with ankylosing spondylitis (AS) and whether the levels correlate with serum cytokine profiles and disease activity of AS. Methods: Forty-two male patients with newly diagnosed AS were enrolled. Their Bath AS Disease Activity Index (BASDAI), body mass index (BMI), and acute phase reactants, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels, were assessed. Serum leptin levels were determined using radioimmunoassay (RIA) and serum cytokine profiles, including tumour necrosis factor (TNF)-α, interleukin (IL)-6, and interferon (IFN)-γ, were determined using enzyme-linked immunosorbent assay (ELISA). These results were compared with those from 42 age-matched healthy men. After a follow-up period of 31.0±20.1 months, clinical and biochemical variables were reassessed in the men with AS. Results: At baseline, patients with AS had significantly elevated serum levels of leptin, leptin adjusted for BMI (leptin/BMI), TNFα, and IL-6, but not IFN-γ, as compared to the controls. Serum leptin/BMI levels correlated well with IL-6 levels, and both leptin/BMI and IL-6 levels correlated well with BASDAI and CRP levels in patients with AS. The changes in leptin/BMI and IL-6 levels between the baseline and follow-up measurements correlated well with one another (p<0.05) and both correlated well with the changes in BASDAI (p<0.05). Conclusion: Serum leptin/BMI levels were increased and significantly associated with IL-6 levels and disease activity in men with AS, suggesting a possible role for leptin in the inflammatory reactions of AS.

AB - Objective: To determine whether serum leptin levels are elevated in men with ankylosing spondylitis (AS) and whether the levels correlate with serum cytokine profiles and disease activity of AS. Methods: Forty-two male patients with newly diagnosed AS were enrolled. Their Bath AS Disease Activity Index (BASDAI), body mass index (BMI), and acute phase reactants, such as erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels, were assessed. Serum leptin levels were determined using radioimmunoassay (RIA) and serum cytokine profiles, including tumour necrosis factor (TNF)-α, interleukin (IL)-6, and interferon (IFN)-γ, were determined using enzyme-linked immunosorbent assay (ELISA). These results were compared with those from 42 age-matched healthy men. After a follow-up period of 31.0±20.1 months, clinical and biochemical variables were reassessed in the men with AS. Results: At baseline, patients with AS had significantly elevated serum levels of leptin, leptin adjusted for BMI (leptin/BMI), TNFα, and IL-6, but not IFN-γ, as compared to the controls. Serum leptin/BMI levels correlated well with IL-6 levels, and both leptin/BMI and IL-6 levels correlated well with BASDAI and CRP levels in patients with AS. The changes in leptin/BMI and IL-6 levels between the baseline and follow-up measurements correlated well with one another (p<0.05) and both correlated well with the changes in BASDAI (p<0.05). Conclusion: Serum leptin/BMI levels were increased and significantly associated with IL-6 levels and disease activity in men with AS, suggesting a possible role for leptin in the inflammatory reactions of AS.

UR - http://www.scopus.com/inward/record.url?scp=34247648780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247648780&partnerID=8YFLogxK

U2 - 10.1080/03009740600991760

DO - 10.1080/03009740600991760

M3 - Article

C2 - 17476615

AN - SCOPUS:34247648780

VL - 36

SP - 101

EP - 106

JO - Scandinavian Journal of Rheumatology

JF - Scandinavian Journal of Rheumatology

SN - 0300-9742

IS - 2

ER -